Abstract:Mechanism underlying the diabetes-induced poor osteointegration of implants remains elusive, making it a challenge to develop corresponding solutions. Here, we studied the role of angiogenesis in the diabetes-induced poor bone repair at the bone-implant interface (BII) and the related mechanisms. In vivo, titanium screws were implanted in the femurs of mice, and, in vitro, vascular endothelial cell (VEC) was cultured on titanium surface. Results showed that, compared with normal milieu (NM), diabetic milieu (DM) led to angiogenesis inhibition around implants which resulted in reduced osteoprogenitors and poor bone formation on Bll in vivo. In vitro, DM caused significant increase of NADPH oxidases (NOX), dysfunction of mitochondria and overproduction of reactive oxygen species (ROS) in VEC on titanium surface, inducing obvious cell dysfunction. Both Mito-TEMPO (Mito, a mitochondria-targeted ROS antagonist) and apocynin (APO, a NOX inhibitor) effectively attenuated the oxidative stress and dysfunction of VEC, with the beneficial effects of APO significantly better than those of Mito. Further study showed that the diabetes-induced metabolic disturbance of VEC was significantly related to the increase of advanced glycation end products (AGEs) at the BB. Our results suggested that the AGEs-related and NOX-triggered cellular oxidative stress leads to VEC dysfunction and angiogenesis impairment at the BB, which plays a critical role in the compromised implant osteointegration under diabetic conditions. These demonstrated new insights into the BII in pathological states and also provided NOX and AGEs as promising therapeutic targets for developing novel implant materials to accelerate the angiogenesis and osteointegration of implants in diabetic patients with hyperglycemia. Statement of Significance The high failure rate of bone implants in diabetic patients causes patients terrible pain and limits the clinical application of implant materials. The mechanism underlying this phenomenon needs elucidation so that it would be possible to develop corresponding solutions. Our study demonstrated that the AGEsrelated and NOX-triggered oxidative stress of VEC leads to angiogenesis impairment at the bone implant interface (BII) in diabetes. These are critical mechanisms underlying the compromised implant osteointegration in diabetic hyperglycemia. These provide new insights into the BII in diseased states and also suggest NOX and AGEs as crucial therapeutic targets for developing novel implant materials which could modulate the oxidative stress on BII to get improved osteointegration and reduced implant failure, especially in diabetic patients. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Biomaterials Designed to Modulate Reactive Oxygen Species for Enhanced Bone Regeneration in Diabetic Conditions

Type 2 Diabetes Mellitus Mediated Oxidative Stress in Bone Tissues and Novel Challenges for Biomaterials

Reactive Oxygen Species (ROS)-Responsive Biomaterials for the Treatment of Bone-Related Diseases

Advances in Material-Based Strategies for Diabetic Bone Regeneration

Macrophage-Centric Biomaterials for Bone Regeneration in Diabetes Mellitus: Contemporary Advancements, Challenges, and Future Trajectories

A Factor-Free Hydrogel with ROS Scavenging and Responsive Degradation for Enhanced Diabetic Bone Healing

Does Oxidative Stress Play a Role in Altered Characteristics of Diabetic Bone? A Systematic Review

Enhancement of Bone Repair in Diabetic Rats with Metformin‐Modified Silicified Collagen Scaffolds

Angiogenesis Impairment by the NADPH Oxidase-Triggered Oxidative Stress at the Bone-Implant Interface: Critical Mechanisms and Therapeutic Targets for Implant Failure under Hyperglycemic Conditions in Diabetes

Advances in Smart Biomaterials That Modulate the Bone Microenvironment to Promote Bone Defect Repair in Diabetes Mellitus

Reactive Oxygen Species-Based Biomaterials for Regenerative Medicine and Tissue Engineering Applications

Piezocatalytic strategy facilitates diabetic bone regeneration through high-performance anti-oxidative recycling

Biomaterials for diabetic bone repair: Influencing mechanisms, multi-aspect progress and future prospects

Reactive Oxygen Species (Ros)-Responsive Biomaterials Mediate Tissue Microenvironments and Tissue Regeneration

Understanding Reactive Oxygen Species in Bone Regeneration: A Glance at Potential Therapeutics and Bioengineering Applications

Inflammation-regulated and Nutrient-Supplied Scaffolds Promote Bone Regeneration in Diabetic Microenvironment in Vivo

Revolutionizing Oral Care: Reactive Oxygen Species (Ros)-Regulating Biomaterials for Combating Infection and Inflammation

Functionalized Metal-Organic Framework-Modified Hydrogel That Breaks the Vicious Cycle of Inflammation and ROS for Repairing of Diabetic Bone Defects

Effect of reactive oxygen species overproduction on osteogenesis of porous titanium implant in the present of diabetes mellitus.

Recent progress in bone-repair strategies in diabetic conditions

Reactive oxygen species-sensitive materials: A promising strategy for regulating inflammation and favoring tissue regeneration